Singapore/New York — Asian stocks rose to a fresh seven-week high on Thursday, lifted by encouraging early results from a Covid-19 treatment trial, though bonds and currencies held cautious ranges ahead of a European Central Bank (ECB) meeting later in the day.

Anthony Fauci, the top US infectious disease official, said Gilead Sciences’s antiviral remdesivir will become the standard of care for Covid-19 after early results from a trial seemed to show it helped speed recovery...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.